Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.
about
Menopause, obesity and inflammation: interactive risk factors for Alzheimer's diseaseBiomarkers of Alzheimer's diseasePlatelet-activating factor enhancement of calcium influx and interleukin-6 expression, but not production, in human microglia.Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's diseaseParkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation.Exploring the Homeostatic and Sensory Roles of the Immune SystemGenetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and TauopathiesDocosahexaenoic Acid and Cognition throughout the LifespanFriends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative DiseasesInsights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based TherapiesRole of pro-inflammatory cytokines released from microglia in Alzheimer's diseaseBioenergetic dysfunction and inflammation in Alzheimer's disease: a possible connectionThe role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?The role of inflammasome in Alzheimer's diseaseInnate immunity in Alzheimer's disease: a complex affairROS and brain diseases: the good, the bad, and the uglyVaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?Inflammation and α-synuclein's prion-like behavior in Parkinson's disease--is there a link?Metabolic syndrome: an important risk factor for Parkinson's diseaseNeuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunityChanges in immune parameters and their correction in human cases of tick-borne encephalitisInflammatory process in Alzheimer's DiseaseCerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's diseaseEvidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposureAntidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophyThe IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signalingGenomic determinants of motor and cognitive outcomes in Parkinson's diseaseThe NALP3 inflammasome is involved in the innate immune response to amyloid-betaTau deposition drives neuropathological, inflammatory and behavioral abnormalities independently of neuronal loss in a novel mouse modelKleemeier Award Lecture 2008--the canary in the coal mine: telomeres and human healthspan.Potential biomarkers relating pathological proteins, neuroinflammatory factors and free radicals in PD patients with cognitive impairment: a cross-sectional studyBrain arachidonic acid cascade enzymes are upregulated in a rat model of unilateral Parkinson diseaseNeural activities of IL-6-type cytokines often depend on soluble cytokine receptors.CSF from Parkinson disease patients differentially affects cultured microglia and astrocytes.LRRK2 levels in immune cells are increased in Parkinson's diseaseBiomarkers of oxidative damage and inflammation in Alzheimer's disease.Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity is increased in Alzheimer disease.Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal β-catenin pathway function in an Alzheimer's disease model.Evidence of inflammatory system involvement in Parkinson's disease.Cytokine signals propagate through the brain.
P2860
Q21131065-E00B8ABA-6FC3-489C-9D76-2D57F07452F9Q24650667-0752E395-1802-4FD2-A9FD-5FAD7E122D01Q24802345-AE166EE8-822D-45C6-8BA5-6918B6B238B8Q24803797-4E4F497C-6A64-4CB3-9CF9-29DAECF1DB9DQ24815148-EEEE4E54-474E-4F15-A92A-C075ECDA6DDEQ26750366-44AB0273-B47A-40DF-832A-01B4FAF2159DQ26767289-F515CEA1-4C6C-4769-B3CE-1381D4FDAC96Q26768442-F68353CE-B987-460E-8127-7D382F7E23BBQ26779933-D0E1249A-14B5-4A95-B0CC-1ED8BF0E6C2CQ26795984-8E36AB57-1CCE-4DAC-9A13-1D1BEEE11B24Q26799870-478FAA35-4960-479D-B4EA-4205227754B2Q26822410-18528E6B-82BD-4740-A31A-BEB084E6AA78Q26861263-7542D22A-B114-46AF-90C5-661D75F2FE60Q26996822-F005F2E6-B4E2-4843-92CF-8B259A70CD9CQ27006944-2A50EDB4-2361-4610-8895-B1814B04EAFCQ27014070-CB75D53F-6F29-4F75-BD3A-64ACD4474E9FQ27015811-D7F3FE8B-F325-4251-9313-68122979EB4FQ27022728-B51DF50A-1E20-41F5-A006-BF849FD0B83CQ27023711-8A8018C4-9488-4B03-AE7E-E5C44ED0C4D5Q27027973-EBC51EA8-2045-4ECC-B715-969CC017BA0FQ27478107-661C7EDF-2607-4E98-A897-9713EB48CDA0Q27500412-30F4307F-7023-4AF2-90FA-0DF80DFA3EDFQ28087176-5924898A-B727-4704-9FD4-E1F240E8B220Q28145614-084348F8-EE3B-4F7E-91E8-E5E8C2564650Q28395248-8A3781A2-FB67-45DC-AB09-DAE4690A6927Q28480459-C83E03FB-0A11-4C6A-B774-A3510292AEBCQ28943408-EF707BF1-85B6-4F3E-8E64-164B49D2F3D9Q29615595-BC86772A-6723-4CAA-AC55-F9F4CA305E06Q30667424-AAD6C4A9-BC19-4B82-ADB9-756F92A20B49Q33567625-0635F3F5-A29A-4484-8164-5A36E0B5D2D0Q33672820-B3C4EF5B-C1BA-417A-99BE-EA47A975E4CCQ33718730-94320B05-3FC7-4816-8534-ADCC6CD54279Q33746118-29259438-66F5-4F4E-A5CB-4AC1095360B3Q33757872-F72438B4-7C9B-419D-A077-74B2A956EF3DQ33765746-5053E788-765E-46FF-8399-ED5B802F97BCQ33771834-58A08FC0-4016-4F32-B572-44AA1767B433Q33803741-D3325B33-8B8F-4B8B-AA55-8E240D25C8EFQ33810933-23E7CFEF-1EE6-4160-AE6E-50173FB8845DQ33890818-A6F82ABB-EC92-4778-B777-C3606885477DQ34111020-4604C0E4-7BE7-46FD-97F1-A11531C3559F
P2860
Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Interleukin-1 beta and interle ...... Parkinson's disease patients.
@en
Interleukin-1 beta and interle ...... Parkinson's disease patients.
@nl
type
label
Interleukin-1 beta and interle ...... Parkinson's disease patients.
@en
Interleukin-1 beta and interle ...... Parkinson's disease patients.
@nl
prefLabel
Interleukin-1 beta and interle ...... Parkinson's disease patients.
@en
Interleukin-1 beta and interle ...... Parkinson's disease patients.
@nl
P2093
P921
P1433
P1476
Interleukin-1 beta and interle ...... Parkinson's disease patients.
@en
P2093
P356
10.1016/0304-3940(95)12192-7
P407
P577
1995-12-01T00:00:00Z